2019 Value Forum

Upcoming Events


Check out the latest edition of HOPA News!

HOPA News Volume 16 issue 2

Latest Discussions

HOPA Bulletin

  • There is substantial variation in breast cancer survival rates, even among patients with similar clinical and genomic profiles. New biomarkers are needed to improve risk stratification and inform treatment options. The aim was to identify novel miRNAs associated with breast cancer survival, and quantify their prognostic value after adjusting for established clinical factors and genomic markers.

Getting Started

Check out our user guide for further information.

Connect With Us